 |
[email protected] |
 |
3275638434 |
 |
 |
| Paper Publishing WeChat |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Taciana Sousa Mutão, Moisés de Sousa Martins Lopes, Emili Galvani de Menezes Ayoub, and Flávia Viecili Tarcha
Full-Text PDF
XML 464 Views
DOI:10.17265/2328-2150/2023.02.002
We report a case of a female patient with breast cancer, emphasizing the importance of a new biopsy of the metastases with the evolution of the disease and the response to alpelisib monotherapy in subsequent lines for triple negative breast cancer (TNBC) with PI3K gene mutation, histological subtype historically with poor outcome and limited treatment options.
Triple-negative breast cancer, PIK3CA gene mutation, Alpelisib.
Mutão, T. S., de Sousa Martins Lopes, M., de Menezes Ayoub, E. G., and Tarcha, F. V. 2023. "Alpelisib Monotherapy in PIK3CA-Mutated Efficacy on Triple-Negative Metastatic Breast Cancer in Subsequent Lines: A Case Report." Journal of Pharmacy and Pharmacology 11 (2): 26-30.